Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
The current price of Merck & Co Inc in the market is $132.11, with a 24-hour trading volume of $200.26M. The asset's market cap is $326.28B, after moving 0.80% in the last day.
Tokenized Merck & Co Inc is trading at $132.69, with a tokenized market cap of $42.78M and a 24-hour trading volume of $668.54K. The tokenized asset has moved 2.44% in the past 24 hours.